Anne Brelot
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Characterizing CCR2 homodimers using homology-derived and AI-predicted interfaces.
Journal: Journal of molecular biology
Published: July 05, 2026
Cryo-CLXEM introduces cryo-SXT to bridge the resolution gap in cryo-CLEM.
Journal: Communications biology
Published: July 22, 2025
SARS-CoV-2 entry and fusion are independent of ACE2 localization to lipid rafts.
Journal: Journal of virology
Published: November 21, 2024
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo.
Journal: Nature communications
Published: November 22, 2023
Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands.
Journal: Molecules (Basel, Switzerland)
Published: December 21, 2022
Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status.
Journal: eLife
Published: December 10, 2021
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.
Journal: Nature communications
Published: May 29, 2019
Targeting CCR5 trafficking to inhibit HIV-1 infection.
Journal: Science advances
Published: February 20, 2019
CCR5 structural plasticity shapes HIV-1 phenotypic properties.
Journal: PLoS pathogens
Published: September 06, 2018
CCR5 adopts three homodimeric conformations that control cell surface delivery.
Journal: Science signaling
Published: May 10, 2018
CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis.
Journal: Journal of molecular biology
Published: April 05, 2018
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
Journal: The Journal of biological chemistry
Published: May 24, 2014
Last Updated: 09/26/2026